CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-26 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | +991 | 990 | ||
| 2024-04-08 | Patel Sanj K CHAIRMAN & CEO | Option exercise | +9,992 | 67,087 | ||
| 2024-04-08 | Patel Sanj K CHAIRMAN & CEO | Shares withheld for taxes | −4,075 | $17.90 | $73K | 63,012 |
| 2024-04-08 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −9,992 | 34,401 | ||
| 2024-04-08 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise | +2,497 | 48,536 | ||
| 2024-04-08 | Paolini John F. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −733 | $17.90 | $13K | 47,803 |
| 2024-04-08 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Unit | −2,497 | 9,375 | ||
| 2024-04-08 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise | +2,694 | 19,562 | ||
| 2024-04-08 | Ragosa Mark CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −791 | $17.90 | $14K | 18,771 |
| 2024-04-08 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | −2,694 | 8,921 | ||
| 2024-04-08 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise | +2,477 | 17,629 | ||
| 2024-04-08 | Moat Ross CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −1,353 | $17.90 | $24K | 16,276 |
| 2024-04-08 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Share Unit | −2,477 | 9,318 | ||
| 2024-04-08 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise | +3,932 | 22,994 | ||
| 2024-04-08 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −1,666 | $17.90 | $30K | 21,328 |
| 2024-04-08 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit | −3,932 | 13,190 | ||
| 2024-04-08 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise | +2,726 | 126,825 | ||
| 2024-04-08 | Tessari Eben CHIEF OPERATING OFFICER | Shares withheld for taxes | −801 | $17.90 | $14K | 126,024 |
| 2024-04-08 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit | −2,726 | 9,573 | ||
| 2024-04-04 | Patel Sanj K CHAIRMAN & CEO | Grant or award · Share Option | +129,750 | 129,750 |
Page 52 of 74 · 1,467 trades